<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">abc</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27982160</article-id><article-id pub-id-type="pmc">5245849</article-id><article-id pub-id-type="doi">10.5935/abc.20160186</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject><subj-group><subject>Metabolism/Nutrition</subject></subj-group></subj-group></article-categories><title-group><article-title>Lifestyle Intervention on Metabolic Syndrome and its Impact on
Quality of Life: A Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Saboya</surname><given-names>Patr&#x000ed;cia Pozas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Bodanese</surname><given-names>Luiz Carlos</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zimmermann</surname><given-names>Paulo Roberto</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gustavo</surname><given-names>Andreia da Silva</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Macagnan</surname><given-names>Fabricio Edler</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Feoli</surname><given-names>Ana Pandolfo</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Margareth da Silva</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Universidade Federal de Ci&#x000ea;ncias da Sa&#x000fa;de de Porto
Alegre - UFCSPA; RS - Brasil</aff><aff id="aff2"><label>2</label>Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul
(PUCRS), RS - Brasil</aff><author-notes><corresp id="c1"><bold>Mailing Address: Patricia Pozas Saboya</bold>, Av. Ipiranga,
6690 / 300 - Postal Code 90610-000, Jardim Bot&#x000e2;nico, RS - Brazil. E-mail:
<email>patricia.saboya@acad.pucrs.br</email>;
<email>ppozassaboya@terra.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>1</month><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>1</month><year>2017</year></pub-date><volume>108</volume><issue>1</issue><fpage>60</fpage><lpage>69</lpage><history><date date-type="received"><day>08</day><month>4</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Lifestyle intervention programs can reduce the prevalence of metabolic
syndrome (MetS) and, therefore, reduce the risk for cardiac disease, one of
the main public health problems nowadays.</p></sec><sec><title>Objective</title><p>The aim of this study was to compare the effects of three types of approach
for lifestyle change programs in the reduction of metabolic parameters, and
to identify its impact on the quality of life (QOL) of individuals with
MetS.</p></sec><sec><title>Methods</title><p>A randomized controlled trial included 72 individuals with MetS aged 30-59
years. Individuals were randomized into three groups of multidisciplinary
intervention [Standard Intervention (SI) - control group; Group Intervention
(GI); and Individual Intervention (II)] during 12 weeks. The primary outcome
was change in the metabolic parameters, and secondarily, the improvement in
QOL measures at three moments: baseline, 3 and 9 months.</p></sec><sec><title>Results</title><p>Group and individual interventions resulted in a significant reduction in
body mass index, waist circumference, systolic blood pressure at 3 months
and the improvement of QOL, although it was significantly associated with
the physical functioning domain. However, these changes did not remain 6
months after the end of intervention. Depression and anxiety were
significantly associated with worse QOL, although they showed no effect on
the response to intervention.</p></sec><sec><title>Conclusion</title><p>Multidisciplinary intervention, especially in a group, might be an effective
and economically feasible strategy in the control of metabolic parameters of
MetS and improvement of QOL compared to SI, even in a dose-effect
relationship.</p></sec></abstract><kwd-group><kwd>Metabolic Syndrome</kwd><kwd>Life Style</kwd><kwd>Quality of Life</kwd><kwd>Cardiovascular Diseases</kwd><kwd>Prevention</kwd><kwd>Risk Factors</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Metabolic syndrome (MetS), considered a complex set of cardiovascular risk factors
related to abdominal fat and resistance to insulin, has been increasing
progressively and is strongly associated with high cardiovascular
morbimortality,<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> with estimated prevalence around
23.7%, according to Adult Treatment Panel III criteria.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> The main recommendations for MetS prevention and
treatment are the change in lifestyle through a multifactor approach based on
education, regular physical exercise and a healthy diet, as well as pharmacological
strategies.<sup><xref rid="r1" ref-type="bibr">1</xref></sup></p><p>Studies show that programs of lifestyle change that include nutritional education and
supervised physical exercise were efficient to achieve the proposed goals for the
treatment of MetS.<sup><xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> However, few studies use this multifactor approach
in their interventions, including all main aspects in the intervention.<sup><xref rid="r6" ref-type="bibr">6</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup></p><p>Furthermore, an increasing number of studies support the idea that MetS is
significantly associated with impaired quality of life (QOL),<sup><xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r13" ref-type="bibr">13</xref></sup> and that this association can be predictive of
mortality.<sup><xref rid="r14" ref-type="bibr">14</xref></sup> Otherwise,
few intervention studies confirm the association between MetS and QOL, showing
improvement in the MetS components, followed by better QOL scores after lifestyle
change intervention,<sup><xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r17" ref-type="bibr">17</xref></sup> in up to 24
months of follow-up.<sup><xref rid="r7" ref-type="bibr">7</xref></sup></p><p>Moreover, studies also show association between depression, anxiety and MetS,
although they are not conclusive. While some studies demonstrate the association
between MetS and depression,<sup><xref rid="r18" ref-type="bibr">18</xref>-<xref rid="r21" ref-type="bibr">21</xref></sup> others reveal only association
between MetS and anxiety.<sup><xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref></sup> For this reason, the analysis of
the prevalence of these clinical situations was carried out in this study in order
to identify whether there is some influence of these variables in the recovery or
the improvement process of the metabolic condition.</p><p>The study of prevention and treatment strategies, as well as the relationship between
MetS and QOL, due to its relevance, complexity and treatment possibility, have been
receiving little attention in medical literature. Thus, the aim of this study is to
test three different programs with a multidisciplinary approach for lifestyle change
in the reduction of metabolic parameters and QOL improvement in the population of a
rapidly developing country.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Participants</title><p>Randomized controlled trial was conducted at the <italic>Centro de
Reabilita&#x000e7;&#x000e3;o do Hospital S&#x000e3;o Lucas da Pontif&#x000ed;cia
Universidade Cat&#x000f3;lica do Rio Grande do Sul</italic> (HSL-PUCRS), a
general university hospital in Southern Brazil. The trial was registered in
clinical trial registry Brazil, ReBEC, number RBR9wz5fc.</p><p>Inclusion criteria: waist circumference (WC) measure &#x0003e; 88 cm for females and
&#x0003e; 102 cm for males, followed by at least two criteria: a) systolic blood
pressure (SBP) &#x02265; 130 mmHg, diastolic blood pressure (DBP) &#x02265; 85
mmHg; b) triglycerides (TGL): &#x02265; 150 mg/dL; c) high-density lipoprotein
cholesterol (HDL-C): &#x0003c; 40 mg/dL for males and &#x0003c; 50 mg/dL for
females;<sup><xref rid="r1" ref-type="bibr">1</xref></sup> and d)
fasting glucose (FG): &#x02265; 100 mg/dL.<sup><xref rid="r2" ref-type="bibr">2</xref></sup></p><p>Exclusion criteria: a) absolute contraindication for physical activity due to
musculoskeletal, neurological, vascular, lung and cardiac problems; b)
pregnancy; c) diagnosis of severe psychiatric disorders, significant cognitive
impairment, assessed by the Mini Mental State Examination (scores under 24 as a
cutoff point); d) unavailability to participate in the program.</p></sec><sec><title>Procedures</title><p>Individuals recruited by media advertising in newspapers, radio and websites
participated in a screening meeting when they were told about the objectives,
inclusion and exclusion criteria of the study. After identifying the
participants who were able to join the study, they were consecutively randomized
into the three kinds of intervention for lifestyle change, by simple
randomization 1:1:1. This procedure occurred successively in four waves till the
sample size was reached.</p><p>After randomization, each individual received the information regarding the
procedures involved in the study, specific for each program, and signed the
written informed consent previously approved by the Ethics Committee in Research
of PUCRS, under number 10/05153. Initial interviews were scheduled, as well as
the following appointments, according to the intervention program drawn. All
interviews and interventions were previously confirmed by telephone and
performed by the researchers, who were submitted to quality standard training
for data collection and intervention procedures.</p><sec><title>Standard intervention</title><p>The standard intervention (SI), considered in this study as the control
group, was the non-pharmacological intervention recommended by the main
guidelines for the clinical management of MetS. The volunteers in this group
had two consultations: at baseline and 3 months. Consultations were carried
out individually by the nursing staff: the first one for standard guidance
on exercising, diet and self-care, according to the guidelines. The diet
program is based on the healthy diet model of the Brazilian Ministry of
Health<sup><xref rid="r24" ref-type="bibr">24</xref></sup> and the
self-care program, focused on the administration of the medications in use
and general health care. The second consultation approached the facility and
difficulty to follow recommendations for changing eating habits and regular
exercising.</p></sec><sec><title>Intervention group</title><p>The group intervention (GI) worked the change in lifestyle through the
discussion of pre-defined themes of health education, focused on the main
cardiovascular risk factors considered changeable which are associated with
MetS, as well as motivation for changing behavior, based on the
transtheoretical model of change.<sup><xref rid="r25" ref-type="bibr">25</xref></sup> The GI appointments occurred weekly during 1 hour
and 45 minutes, coordinated by a psychologist, a nurse, a physical therapist
and a nutritionist. During the first 45 minutes, volunteers discussed a
health topic proposed by the team. Soon after that, they discussed and
tested strategies for changing eating habits and regular exercising, which
could be included in the volunteers' routine, according to the group's
motivation. The groups were composed of 10 to 12 individuals.</p></sec><sec><title>Individual intervention</title><p>The volunteers in the individual intervention (II) group participated in
weekly individual appointments with the psychology and nutrition teams, and
exercised regularly with the physical therapy team.</p><p>Nutritional intervention: based on the needs of each participant according to
the aspects that should be changed, respecting intrinsic and extrinsic
conditions necessary for the changing process of eating habits. During the
weekly appointments, body weight was measured and adhesion to the diet
program was assessed through a brief 24-hour recall. In addition, possible
difficulties in the adhesion to the strategies and goals agreed in the
previous consultation were constantly recorded and monitored. MetS-related
themes were developed based on a pre-defined program and addressed
individually, aiming to improve the understanding and adhesion to the
strategies for changing eating habits.</p><p>Psychological intervention: based on the transtheoretical model of
change,<sup><xref rid="r25" ref-type="bibr">25</xref></sup> adapted
for individual model, which worked on the different stages of change based
on a structured program, with pre-defined objectives, as well as the
specific change processes. Materials such as flyers were used and filled out
by the volunteer.</p><p>Physical intervention: composed of 36 sessions on the treadmill for 60
continuous minutes each. They occurred three times a week, and the intensity
was adjusted according to the recommended heart rate (HR) for each
individual. The training range remained between 75% and 85% of the maximum
HR, assessed by the graded exercise test (GXT). During physical exercise,
BP, HR and symptoms of cardiovascular alterations were monitored. The speed
and inclination were constantly adjusted to keep HR within the training
range.</p></sec><sec><title>Measurements</title><p>All groups were assessed at baseline, end of interventions (3 months), and 6
months later (9 months). The assessment comprised physical, metabolic,
behavioral and psychological aspects of the individuals studied.</p></sec><sec><title>Sociodemographic data</title><p>Data on personal identification, psychosocial and health aspects, such as
diagnosis, medications in use and lifestyle (smoking habit, use of alcohol,
physical activity), were collected in individual interviews by use of a
structured questionnaire.</p><p>Alcohol use: male intake - up to 1 oz (30 ml) of ethanol/day; female intake -
up to 0.5 oz of ethanol/day.<sup><xref rid="r26" ref-type="bibr">26</xref></sup></p><p>Physical activity: exercise at least once a week as opposed to no exercise,
the latter characterizing a sedentary lifestyle.</p></sec><sec><title>Clinical parameters</title><p>The anthropometric profile assessment included measuring WC, with a
millimeter non-extensible long tape at the abdomen's maximum
extension,<sup><xref rid="r27" ref-type="bibr">27</xref></sup> body
weight, and height, to calculate body mass index (BMI). Individuals were
barefoot and lightly dressed having body weight measured, through the use of
a properly calibrated 160-kg Cauduro<sup>&#x000ae;</sup> scale. The
Sunny<sup>&#x000ae;</sup> vertical anthropometer was used for measuring
height. Blood pressure values were assessed in three consecutive
measurements, according to the American Hypertension Guidelines.<sup><xref rid="r26" ref-type="bibr">26</xref></sup></p></sec><sec><title>Laboratory parameters</title><p>Blood samples were collected after fasting for the analysis of biochemical
markers. Plasma and serum were separated and stored at -80&#x000b0;C for later
analyses at HSL-PUCRS' laboratory. The tests analyzed were FG, total
cholesterol, HDL-C and TGL, while low-density protein was determined
indirectly.</p></sec><sec><title>Depression and anxiety</title><p>These variables were measured through the Adult Self Report (ASR),<sup><xref rid="r28" ref-type="bibr">28</xref></sup> self-administered scale of
126 items that aims to identify the aspects of adults' adaptive functioning
between the ages of 19 and 59 years, identifying behavioral and emotional
problems and higher incidence of psychopathological disorders, such as
anxiety and depression. Scores range from 0 to 100, with higher scores
indicating a greater number of behavioral problems. Individuals with scores
above 60 within the internalization scale, who demonstrate borderline and
clinical status or under drug treatment, were classified as depressed or
anxious.</p></sec><sec><title>Quality of life</title><p>This variable was assessed using the Medical Outcomes Study Short Form,
General Health Survey (SF-36)<sup><xref rid="r29" ref-type="bibr">29</xref></sup> that evaluates the QOL of individuals in relation to
their disease. It consists of 36 questions, divided into the following 8
domains: physical functioning; limitations due to physical problem; bodily
pain; general health perceptions; vitality; social functioning; role
limitations due to emotional problems; and mental health. These domains were
summarized into Physical and Mental Component Summary (PCS and MCS,
respectively). The scores range from 0 to 100 for each domain, in which
higher scores indicate better QOL.</p></sec></sec><sec><title>Statistical analysis</title><p>For &#x003b1; = 0.05, 90% power and estimating a difference between WC averages of
0.9 units of standard deviation, a sample number of 27 volunteers in each group
was calculated. Considering maximum loss of 20%, the sample size became 34 per
group.</p><p>Quantitative data were described as mean and standard deviation. Categorical
variables were presented as counts and percentages. Comparisons of quantitative
data used the one-way Anova for 3 groups and <italic>t</italic> test for 2
groups. For categorical data, we used the chi-square and Fisher's exact test,
when necessary. To evaluate the outcomes, MetS components and QOL scores,
considering adjustment for confounding factors, analysis of covariance and
multiple linear regression were used. Additionally, analysis of covariance was
used for comparisons at 3 and 9 months, adjusting for baseline measures and
other confounding factors. The results were subjected to statistical analysis
using the Statistical Package for Social Sciences (SPSS) program, version 21,
with an alpha level of significance at 5%.</p></sec></sec><sec sec-type="results"><title>Results</title><p>This study included 72 individuals who concluded the intervention, divided into three
groups: SI, 19; GI, 25; and II, 28 (<xref ref-type="fig" rid="f1">Figure 1</xref>).
Individuals who did not complete the trial and the ones that remained in the study
showed similar characteristics regarding race, marital status and BMI. However,
there were more women with lower levels of education (data not shown).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow chart of study participants.</p></caption><graphic xlink:href="abc-108-01-0060-g01"/></fig>
</p><p>According to <xref ref-type="table" rid="t1">Table 1</xref>, most of the population
studied was female, white and had high levels of education. Groups showed similar
distributions in terms of general characteristics, as well as MetS and QOL
components, without statistically significant differences at baseline.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the study participants</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">SI</th><th align="center" rowspan="1" colspan="1">GI</th><th align="center" rowspan="1" colspan="1">II</th><th rowspan="2" align="center" colspan="1">p</th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>n=19</bold></th><th align="center" rowspan="1" colspan="1"><bold>n=25</bold></th><th align="center" rowspan="1" colspan="1"><bold>n=28</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years</td><td align="center" rowspan="1" colspan="1">52.1&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">50.9&#x000b1;7.7</td><td align="center" rowspan="1" colspan="1">51.6&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">0.831 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Female, n (%)</td><td align="center" rowspan="1" colspan="1">7 (36.8)</td><td align="center" rowspan="1" colspan="1">13 (52.0)</td><td align="center" rowspan="1" colspan="1">20 (71.4)</td><td align="center" rowspan="1" colspan="1">0.055 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">White, n (%)</td><td align="center" rowspan="1" colspan="1">17 (89.5)</td><td align="center" rowspan="1" colspan="1">23 (92.0)</td><td align="center" rowspan="1" colspan="1">24 (85.7)</td><td align="center" rowspan="1" colspan="1">0.763 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Marital status, n (%)</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.768 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">With companion</td><td align="center" rowspan="1" colspan="1">12 (66.7)</td><td align="center" rowspan="1" colspan="1">15 (71.4)</td><td align="center" rowspan="1" colspan="1">17 (68.0)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Single</td><td align="center" rowspan="1" colspan="1">3 (16.7)</td><td align="center" rowspan="1" colspan="1">5 (23.8)</td><td align="center" rowspan="1" colspan="1">6 (24.0)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Widowed</td><td align="center" rowspan="1" colspan="1">3 (16.7)</td><td align="center" rowspan="1" colspan="1">1 (4.8)</td><td align="center" rowspan="1" colspan="1">3 (16.7)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Level of education, n (%)</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.424 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">4 years of study</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">1 (3.6)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">5 to 8 years of study</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">1 (3.6)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Over 9 years of study</td><td align="center" rowspan="1" colspan="1">19 (100.0)</td><td align="center" rowspan="1" colspan="1">25 (100.0)</td><td align="center" rowspan="1" colspan="1">26 (92.9)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Sedentary lifestyle, n (%)</td><td align="center" rowspan="1" colspan="1">11 (57.9)</td><td align="center" rowspan="1" colspan="1">16 (64.0)</td><td align="center" rowspan="1" colspan="1">21 (75.0)</td><td align="center" rowspan="1" colspan="1">0.442 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking, n (%)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">2 (8.0)</td><td align="center" rowspan="1" colspan="1">1 (3.6)</td><td align="center" rowspan="1" colspan="1">0.305 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Use of alcohol, n (%)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">2 (8.0)</td><td align="center" rowspan="1" colspan="1">2 (7.1)</td><td align="center" rowspan="1" colspan="1">0.280 <xref ref-type="table-fn" rid="TFN2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">33.5&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">35.1&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">33.7&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">0.283 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>MetS Components</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">WC (cm)</td><td align="center" rowspan="1" colspan="1">112.6&#x000b1;8.3</td><td align="center" rowspan="1" colspan="1">112.9&#x000b1;10.0</td><td align="center" rowspan="1" colspan="1">110.7&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">0.605 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mmHg)</td><td align="center" rowspan="1" colspan="1">132.6&#x000b1;10.3</td><td align="center" rowspan="1" colspan="1">131.8&#x000b1;15.2</td><td align="center" rowspan="1" colspan="1">135.5&#x000b1;13.5</td><td align="center" rowspan="1" colspan="1">0.577 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mmHg)</td><td align="center" rowspan="1" colspan="1">90.6&#x000b1;10.3</td><td align="center" rowspan="1" colspan="1">89.7&#x000b1;12.7</td><td align="center" rowspan="1" colspan="1">89.2&#x000b1;11.6</td><td align="center" rowspan="1" colspan="1">0.922 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">TGL (mg/dL)</td><td align="center" rowspan="1" colspan="1">174.6&#x000b1;60.2</td><td align="center" rowspan="1" colspan="1">266.5&#x000b1;227.0</td><td align="center" rowspan="1" colspan="1">200.4&#x000b1;84.9</td><td align="center" rowspan="1" colspan="1">0.101 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-C (mg/dL)</td><td align="center" rowspan="1" colspan="1">46.4&#x000b1;8.9</td><td align="center" rowspan="1" colspan="1">47.7&#x000b1;11.3</td><td align="center" rowspan="1" colspan="1">48.2&#x000b1;14.1</td><td align="center" rowspan="1" colspan="1">0.872 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SF-36</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical functioning</td><td align="center" rowspan="1" colspan="1">76.8&#x000b1;20.6</td><td align="center" rowspan="1" colspan="1">74.8&#x000b1;18.1</td><td align="center" rowspan="1" colspan="1">77.0&#x000b1;17.2</td><td align="center" rowspan="1" colspan="1">0.898 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Role-physical</td><td align="center" rowspan="1" colspan="1">75.0&#x000b1;35.4</td><td align="center" rowspan="1" colspan="1">77.1&#x000b1;26.5</td><td align="center" rowspan="1" colspan="1">86.6&#x000b1;30.0</td><td align="center" rowspan="1" colspan="1">0.365 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Bodily pain</td><td align="center" rowspan="1" colspan="1">62.8&#x000b1;21.9</td><td align="center" rowspan="1" colspan="1">63.6&#x000b1;21.5</td><td align="center" rowspan="1" colspan="1">70.9&#x000b1;22.8</td><td align="center" rowspan="1" colspan="1">0.369 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">General health</td><td align="center" rowspan="1" colspan="1">73.2&#x000b1;14.8</td><td align="center" rowspan="1" colspan="1">72.8&#x000b1;18.3</td><td align="center" rowspan="1" colspan="1">72.0&#x000b1;18.6</td><td align="center" rowspan="1" colspan="1">0.973 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Vitality</td><td align="center" rowspan="1" colspan="1">58.9&#x000b1;22.9</td><td align="center" rowspan="1" colspan="1">61.0&#x000b1;22.7</td><td align="center" rowspan="1" colspan="1">58.9&#x000b1;22.0</td><td align="center" rowspan="1" colspan="1">0.933 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Social functioning</td><td align="center" rowspan="1" colspan="1">82.4&#x000b1;23.5</td><td align="center" rowspan="1" colspan="1">78.3&#x000b1;23.8</td><td align="center" rowspan="1" colspan="1">80.8&#x000b1;16.3</td><td align="center" rowspan="1" colspan="1">0.810 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Role emotional</td><td align="center" rowspan="1" colspan="1">80.7&#x000b1;25.6</td><td align="center" rowspan="1" colspan="1">72.0&#x000b1;39.3</td><td align="center" rowspan="1" colspan="1">70.2&#x000b1;38.8</td><td align="center" rowspan="1" colspan="1">0.600 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Mental health</td><td align="center" rowspan="1" colspan="1">71.6&#x000b1;18.8</td><td align="center" rowspan="1" colspan="1">71.7&#x000b1;22.8</td><td align="center" rowspan="1" colspan="1">68.9&#x000b1;16.8</td><td align="center" rowspan="1" colspan="1">0.842 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Physical component summary</td><td align="center" rowspan="1" colspan="1">46.8&#x000b1;8.5</td><td align="center" rowspan="1" colspan="1">47.2&#x000b1;6.8</td><td align="center" rowspan="1" colspan="1">49.9&#x000b1;5.5</td><td align="center" rowspan="1" colspan="1">0.227 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Mental component summary</td><td align="center" rowspan="1" colspan="1">50.2&#x000b1;10.2</td><td align="center" rowspan="1" colspan="1">48.9&#x000b1;14.1</td><td align="center" rowspan="1" colspan="1">47.1&#x000b1;9.7</td><td align="center" rowspan="1" colspan="1">0.664 <xref ref-type="table-fn" rid="TFN1">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>ANOVA;</p></fn><fn id="TFN2"><label>&#x02020;</label><p>Chi-square test; SI: standard intervention; GI: group intervention; II:
individual intervention; BMI: body mass index; MetS: metabolic syndrome;
WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic
blood pressure; TGL: triglycerides; HDL-C- High: density lipoprotein
cholesterol.</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="t2">Table 2</xref> presents results regarding MetS
components in the three types of intervention. Although there was a reduction in
TGL, FG and DBP, only BMI, WC and SBP showed significant reduction in their mean
scores after 12 weeks. Compared to baseline, only II was associated with a
significant reduction in SBP levels. On the other hand, regarding BMI and WC, both
the GI and II showed a significant reduction in their mean scores, and GI was more
effective in the reduction of BMI (<xref ref-type="fig" rid="f2">Figure
2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparisons between the 3 groups at 3 and 9 months in metabolic parameters by
ANCOVA</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="18%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="5%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="5%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/></colgroup><thead><tr style="border-bottom-width:thin;border-bottom-style:solid"><th align="left" rowspan="2" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">SI</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">GI</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">II</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th rowspan="2" align="center" colspan="1">p</th><th rowspan="2" align="center" colspan="1">p <xref ref-type="table-fn" rid="TFN3">*</xref></th></tr><tr><th align="center" rowspan="1" colspan="1">Month 3 <break/>(n=19)</th><th align="center" rowspan="1" colspan="1">Month 9<break/> (n=17)</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Month 3<break/> (n=25)</th><th align="center" rowspan="1" colspan="1">Month 9<break/> (n=21)</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Month 3<break/> (n=28)</th><th align="center" rowspan="1" colspan="1">Month 9<break/> (n=20)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>MetS Components</bold></td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">33.7&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">33.2&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">33.3&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">33.5&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">32.2&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">32.4&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">0.144</td></tr><tr><td align="left" rowspan="1" colspan="1">WC (cm)</td><td align="center" rowspan="1" colspan="1">110.2&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">108.0&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">108.5&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">108.0&#x000b1;1.1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">105.4&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">106.4&#x000b1;1.1</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">0.522</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mmHg)</td><td align="center" rowspan="1" colspan="1">134.3&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">132.9&#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">130.6&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">128.8&#x000b1;3.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">120.6&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">124.6&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.330</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mmHg)</td><td align="center" rowspan="1" colspan="1">86.4&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">85.6&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">84.6&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">82.8&#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">80.9&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">80.7&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">0.199</td><td align="center" rowspan="1" colspan="1">0.263</td></tr><tr><td align="left" rowspan="1" colspan="1">TGL (mg/dL)</td><td align="center" rowspan="1" colspan="1">215.0&#x000b1;14.5</td><td align="center" rowspan="1" colspan="1">182.1&#x000b1;19.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">203.6&#x000b1;12.8</td><td align="center" rowspan="1" colspan="1">210.7&#x000b1;16.1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">176.2&#x000b1;12.3</td><td align="center" rowspan="1" colspan="1">203.4&#x000b1;15.9</td><td align="center" rowspan="1" colspan="1">0.103</td><td align="center" rowspan="1" colspan="1">0.539</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-C (mg/dL)</td><td align="center" rowspan="1" colspan="1">43.6&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">45.2&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">48.0&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">47.4&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">46.9&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">46.3&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">0.060</td><td align="center" rowspan="1" colspan="1">0.616</td></tr><tr><td align="left" rowspan="1" colspan="1">FG (mg/dL)</td><td align="center" rowspan="1" colspan="1">111.0&#x000b1;4.3</td><td align="center" rowspan="1" colspan="1">112.3&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">107.7&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">106.9&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">99.5&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">105.6&#x000b1;4.3</td><td align="center" rowspan="1" colspan="1">0.108</td><td align="center" rowspan="1" colspan="1">0.600</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>p: statistical significance at 3 months; p *: statistical significance at
9 months; SI: standard intervention; GI: group intervention; II:
individual intervention; MetS: metabolic syndrome; BMI: body mass index;
WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic
blood pressure; TGL: triglycerides; HDL-C: highdensity lipoprotein
cholesterol; FG: Fasting glucose.</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>BMI, WC, SBP and Physical Functioning measures at baseline and 3 months.
BMI: body mass index; WC: waist circumference; SBP: systolic blood
pressure; SI: Standard Intervention; GI: Group Intervention; II:
Individual intervention.</p></caption><graphic xlink:href="abc-108-01-0060-g02"/></fig>
</p><p>Regarding QOL scores, almost all domains in all types of intervention showed an
increase in their mean scores after 12 weeks. However, only physical functioning
showed significant association (p=0.024), although general health had borderline
significance. Compared to baseline, in almost all SF-36 domains, QOL improvement was
higher in the II, although no statistically significant difference among the groups
was found. Considering the PCS and MCS scores, no significant difference was found
after the intervention. Similarly, there was no significant difference among the
groups, despite the fact that II encouraged a larger increase in the MCS (<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparisons between the 3 groups at 3 and 9 months in the QOL domains by
ANCOVA</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/></colgroup><thead><tr style="border-bottom-width:thin;border-bottom-style:solid"><th align="left" rowspan="2" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">SI</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">GI</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">II</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th rowspan="2" align="center" colspan="1">p</th><th rowspan="2" align="center" colspan="1">p <xref ref-type="table-fn" rid="TFN4">*</xref></th></tr><tr><th align="center" rowspan="1" colspan="1">Month 3<break/> (n=19)</th><th align="center" rowspan="1" colspan="1">Month 9<break/> (n=17)</th><th align="center" rowspan="1" colspan="1">Month 3<break/> (n=25)</th><th align="center" rowspan="1" colspan="1">Month 9<break/> (n=21)</th><th align="center" rowspan="1" colspan="1">Month 3<break/> (n=28)</th><th align="center" rowspan="1" colspan="1">Month 9<break/> (n=20)</th></tr></thead><tbody><tr><td align="left" colspan="9" rowspan="1"><bold>SF-36</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">PF</td><td align="center" rowspan="1" colspan="1">76.7&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">76.8&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">78.3&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">78.5&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">87.7&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">75.3&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">0.024</td><td align="center" rowspan="1" colspan="1">0.865</td></tr><tr><td align="left" rowspan="1" colspan="1">RP</td><td align="center" rowspan="1" colspan="1">83.6&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">86.5&#x000b1;9.0</td><td align="center" rowspan="1" colspan="1">92.1&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">73.7&#x000b1;8.1</td><td align="center" rowspan="1" colspan="1">88.4&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">82.7&#x000b1;8.2</td><td align="center" rowspan="1" colspan="1">0.488</td><td align="center" rowspan="1" colspan="1">0.543</td></tr><tr><td align="left" rowspan="1" colspan="1">BP</td><td align="center" rowspan="1" colspan="1">72.8&#x000b1;5.0</td><td align="center" rowspan="1" colspan="1">70.5&#x000b1;5.4</td><td align="center" rowspan="1" colspan="1">73.3&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">65.9&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">79.3&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">61.7&#x000b1;5.1</td><td align="center" rowspan="1" colspan="1">0.511</td><td align="center" rowspan="1" colspan="1">0.513</td></tr><tr><td align="left" rowspan="1" colspan="1">GH</td><td align="center" rowspan="1" colspan="1">79.6&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">79.5&#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">78.0&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">76.2&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">85.8&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">78.8&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">0.057</td><td align="center" rowspan="1" colspan="1">0.799</td></tr><tr><td align="left" rowspan="1" colspan="1">VT</td><td align="center" rowspan="1" colspan="1">69.5&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">66.9&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">71.2&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">64.3&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">77.6&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">68.9&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">0.096</td><td align="center" rowspan="1" colspan="1">0.732</td></tr><tr><td align="left" rowspan="1" colspan="1">SF</td><td align="center" rowspan="1" colspan="1">84.2&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">78.9&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">87.2&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">78.5&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">92.7&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">81.2&#x000b1;5.1</td><td align="center" rowspan="1" colspan="1">0.272</td><td align="center" rowspan="1" colspan="1">0.922</td></tr><tr><td align="left" rowspan="1" colspan="1">RE</td><td align="center" rowspan="1" colspan="1">88.8&#x000b1;6.8</td><td align="center" rowspan="1" colspan="1">79.6&#x000b1;7.3</td><td align="center" rowspan="1" colspan="1">80.2&#x000b1;5.9</td><td align="center" rowspan="1" colspan="1">87.9&#x000b1;6.6</td><td align="center" rowspan="1" colspan="1">88.4&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">81.7&#x000b1;6.7</td><td align="center" rowspan="1" colspan="1">0.522</td><td align="center" rowspan="1" colspan="1">0.676</td></tr><tr><td align="left" rowspan="1" colspan="1">MH</td><td align="center" rowspan="1" colspan="1">77.8&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">72.9&#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">76.1&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">77.3&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">82.7&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">75.1&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">0.163</td><td align="center" rowspan="1" colspan="1">0.708</td></tr><tr><td align="left" rowspan="1" colspan="1">PCS</td><td align="center" rowspan="1" colspan="1">49.2&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">50.3&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">50.6&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">46.7&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">51.8&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">47.2&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">0.444</td><td align="center" rowspan="1" colspan="1">0.477</td></tr><tr><td align="left" rowspan="1" colspan="1">MCS</td><td align="center" rowspan="1" colspan="1">53.2&#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">49.8&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">52.2&#x000b1;1.6</td><td align="center" rowspan="1" colspan="1">52.5&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">55.2&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">52.4&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">0.377</td><td align="center" rowspan="1" colspan="1">0.606</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>p: statistical significance at 3 months; p *: statistical significance at
9 months; SI: standard intervention; GI: group intervention; II:
individual intervention; SF-36: Medical Outcome Study Short Form General
Health Survey; PF: physical functioning; RP: Rrle-physical; BP: bodily
pain; GH: general health; VT: vitality; SF: social functioning; RE:
role-emotional; MH: mental health; PCS: physical component summary; MCS:
mental component summary.</p></fn></table-wrap-foot></table-wrap><p>Nevertheless, these results concerning the improvement of metabolic parameters, as
well as QOL, were not kept 6 months after the end of intervention.</p><p>The prevalence of anxiety and depression was 41.7% and 22.2%, respectively. Regarding
metabolic parameters, there was no significant association between MetS components
and depression and anxiety. Concerning QOL, the mean scores for individuals with
anxiety were lower in all SF-36 domains compared to those who did not have anxiety,
although they were significant only in 5 domains (<xref ref-type="table" rid="t4">Table 4</xref>).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Averages of the SF-36 scores of individuals with depression (DEP) and without
depression (N-DEP) and with anxiety (ANX) and without anxiety (N-ANX)</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="16%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables <break/>(n=72)</th><th align="center" rowspan="1" colspan="1">DEP</th><th align="center" rowspan="1" colspan="1">N-DEP</th><th align="center" rowspan="1" colspan="1">p</th><th align="center" rowspan="1" colspan="1">ANX</th><th align="center" rowspan="1" colspan="1">N-ANX</th><th align="center" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1"><bold>SF-36</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Physical functioning</td><td align="center" rowspan="1" colspan="1">73.1&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">77.0&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">0.502</td><td align="center" rowspan="1" colspan="1">75.0&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">77.0&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">0.643</td></tr><tr><td align="left" rowspan="1" colspan="1">Role-physical</td><td align="center" rowspan="1" colspan="1">54.7&#x000b1;8.9</td><td align="center" rowspan="1" colspan="1">87.7&#x000b1;3.3</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">76.7&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">82.9&#x000b1;5.0</td><td align="center" rowspan="1" colspan="1">0.388</td></tr><tr><td align="left" rowspan="1" colspan="1">Bodily pain</td><td align="center" rowspan="1" colspan="1">52.2&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">70.2&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">59.1&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">71.3&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">0.016</td></tr><tr><td align="left" rowspan="1" colspan="1">General health</td><td align="center" rowspan="1" colspan="1">65.7&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">74.6&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">0.107</td><td align="center" rowspan="1" colspan="1">70.9&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">73.8&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">0.471</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitality</td><td align="center" rowspan="1" colspan="1">45.9&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">63.6&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">0.007</td><td align="center" rowspan="1" colspan="1">51.7&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">65.3&#x000b1;3.4</td><td align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">Social functioning</td><td align="center" rowspan="1" colspan="1">64.4&#x000b1;6.9</td><td align="center" rowspan="1" colspan="1">85.0&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">0.011</td><td align="center" rowspan="1" colspan="1">72.3&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">86.2&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Role-emotional</td><td align="center" rowspan="1" colspan="1">45.8&#x000b1;10.0</td><td align="center" rowspan="1" colspan="1">81.5&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">0.004</td><td align="center" rowspan="1" colspan="1">61.1&#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">82.5&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">0.018</td></tr><tr><td align="left" rowspan="1" colspan="1">Mental health</td><td align="center" rowspan="1" colspan="1">53.5&#x000b1;5.5</td><td align="center" rowspan="1" colspan="1">75.4&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">61.7&#x000b1;3.8</td><td align="center" rowspan="1" colspan="1">76.9&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>t test; SF-36- Medical Outcome Study Short Form General Health
Survey.</p></fn></table-wrap-foot></table-wrap><p>Among the individuals who had depression, besides the lower QOL mean scores, all QOL
domains, except for physical functioning and general health, showed significant
difference when compared to those who did not have depression (<xref ref-type="table" rid="t4">Table 4</xref>). Regarding the influence of anxiety
and depression in the intervention response, this study demonstrated that only
depression had a negative significant effect on the scores of the SF-36 role
emotional domain, although there was no statistical difference among the groups
analyzed. MetS components, as well as the other QOL domains, showed no association
with depression and anxiety.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>This study tested 3 types of multidisciplinary intervention for lifestyle change in
individuals with MetS, followed during 9 months, to determine its effects in the
reduction of metabolic parameters and improvement of QOL. Results suggest that GI,
as well as II were associated with significant BMI and WC reduction although only II
had been significantly associated with lower SBP levels, which partially confirms
the hypothesis previously established. It was surprising that GI reduced BMI levels
more than II. According to a previous study,<sup><xref rid="r30" ref-type="bibr">30</xref></sup> which demonstrated that standard advice is not sufficient
to obtain changes in lifestyle and cardiovascular risk factors, SI, even showing a
slight reduction in WC, did not have positive results in the improvement of the
other metabolic parameters or statistically significant improvements in QOL, and II
and GI showed a better response to intervention. Despite the fact that GI showed a
smaller WC reduction than II, considering the fact that a 3-cm reduction already
results in significant improvement of cardiometabolic risk factors,<sup><xref rid="r31" ref-type="bibr">31</xref></sup> GI proved effective once it
promoted a 4.4-cm reduction.</p><p>In accordance with previous reports,<sup><xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup> this study demonstrated that lifestyle
intervention produced beneficial effects on metabolic parameters, especially on
weight loss and WC, and the average of WC reduction in the II group was similar to
the one found in individuals who underwent an intensive lifestyle intervention
program.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> However, the
present study, including all interventions, did not show statistically significant
effects on FG, TGL,<sup><xref rid="r32" ref-type="bibr">32</xref></sup> DBP and
HDL-C.<sup><xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r32" ref-type="bibr">32</xref></sup> Although this study demonstrated improvement in
QOL in both groups after intervention, in accordance with previous
studies,<sup><xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r32" ref-type="bibr">32</xref></sup> only the physical functioning domain, also shown in other
studies,<sup><xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> showed a significant association. However,
opposing data from most studies which demonstrated that QOL improvement is
maintained after intervention for a period of 12,<sup><xref rid="r9" ref-type="bibr">9</xref></sup> 24<sup><xref rid="r17" ref-type="bibr">17</xref></sup> and
up to 36 months,<sup><xref rid="r7" ref-type="bibr">7</xref></sup> this study showed
this effect only after the end of intervention.<sup><xref rid="r32" ref-type="bibr">32</xref></sup> Due to the fact that there are no studies comparing the
different approaches for individual and group lifestyle interventions in individuals
with MetS, the finding that II showed higher effect on most QOL domains suggests
that this result might be attributed to the intensity of intervention. This occurs
because, according to the results of previous studies comparing types of
intervention related to their intensity (moderate x intensive), the individuals who
took part in more intensive programs showed significantly better results in weight
reduction<sup><xref rid="r33" ref-type="bibr">33</xref></sup> and in most
QOL domains.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> Similarly, it is
inconclusive whether this improvement in QOL might be related to weight loss, due to
the relationship between BMI increase and QOL impairment,<sup><xref rid="r34" ref-type="bibr">34</xref></sup> improvement in the physical condition<sup><xref rid="r16" ref-type="bibr">16</xref></sup> or both.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p><p>Another important contribution of this study is the fact that it demonstrated the
influence of depression and anxiety in the reduction of scores in most QOL domains
for individuals with MetS. Previous studies have already shown the association
between MetS and depression and anxiety,<sup><xref rid="r18" ref-type="bibr">18</xref>-<xref rid="r23" ref-type="bibr">23</xref></sup> but only a few
analyzed its impact on QOL.<sup><xref rid="r35" ref-type="bibr">35</xref></sup>
Despite the fact that there was no significant influence of these variables in the
response to intervention, deserves attention, as these clinical situations lead to
QOL impairment, which justifies the importance of screening individuals with MetS
for depression and anxiety.</p><p>This study provides preliminary data that a group intervention program can present
results similar to individual intervention and, for this reason, might be an
important prevention strategy, although its effects were not kept after the
intervention. Therefore, it seems important to carry out a regular follow-up, as
well as measures that encourage individuals to continue the lifestyle changes to
maintain these effects. Moreover, group programs for lifestyle change seem to be an
alternative intervention strategy that presents the best cost-benefit ratio in the
management of metabolic parameters, as well as QOL of individuals who suffer from
this important clinical condition nowadays.</p><p>A limiting factor in this study was the dropout rate, which hindered the use of the
intention to treat analysis. Although this rate was similar between GI and II
interventions, SI presented a high figure. A possible explanation for this can
relate to the fact that the SI did not meet the individuals' expectations, since
they were looking for a new type of intervention. Although the dropout occurred
during follow-up, individuals who did not complete the study showed no significant
differences when compared to individuals who remained in the study, which might
minimize the effect of these losses. Another limiting factor concerns the relatively
small intervention period of 12 weeks. Although this is the period normally used in
other trials, metabolic parameters and QOL improvement results might have been kept
if the intervention had lasted longer.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Multidisciplinary intervention, especially in a group, might be an effective and
economically feasible strategy to control the metabolic parameters of MetS and
improvement of QOL compared to SI, even in a dose-effect relationship.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions</bold></p><p>Conception and design of the research and Analysis and interpretation of the
data: Saboya PP, Bodanese LC, Zimmermann PR, Gustavo AS; Acquisition of data:
Saboya PP, Gustavo AS, Macagnan FE, Feoli AP, Oliveira MS; Statistical analysis
and Writing of the manuscript: Saboya PP; Obtaining financing: Gustavo AS,
Macagnan FE, Feoli AP, Oliveira MS; Critical revision of the manuscript for
intellectual content: Saboya PP, Bodanese LC, Zimmermann PR, Gustavo AS,
Macagnan FE, Feoli AP, Oliveira MS.</p></fn><fn fn-type="COI-statement"><p><bold>Potential Conflict of Interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="supported-by"><p><bold>Sources of Funding</bold></p><p>This study was funded by CNPq.</p></fn><fn fn-type="other"><p><bold>Study Association</bold></p><p>This article is part of the thesis of Doctoral submitted by Patr&#x000ed;cia Pozas
Saboya, from Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do
Sul.</p></fn></fn-group><ack><title>Acknowledgments</title><p>The authors thank their colleagues of the MERC research group, for their
collaboration, especially academic students, for helping with data collection. We
also thank Isabel Merlo Crespo for her important collaboration in our library
searches and Dr. M&#x000e1;rio Wagner for the statistical work developed throughout
the project.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults</collab></person-group><article-title>Executive Summary of The Third Report of The National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation, And
Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel
III)</article-title><source>JAMA</source><year>2001</year><volume>285</volume><issue>19</issue><fpage>2486</fpage><lpage>2497</lpage><pub-id pub-id-type="pmid">11368702</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>International Diabetes Federation. (IDF)</collab></person-group><source>The IDF consensus worldwide definition of the metabolic
syndrome</source><publisher-loc>Brussels</publisher-loc><year>2006</year></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>ES</given-names></name><name><surname>Giles</surname><given-names>WH</given-names></name><name><surname>Dietz</surname><given-names>WH</given-names></name></person-group><article-title>Prevalence of the metabolic syndrome amoung US adults: findings
from the third National Health and Nutrition Examination
Survey</article-title><source>JAMA</source><year>2002</year><volume>287</volume><issue>3</issue><fpage>356</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">11790215</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kukkonen-Harjula</surname><given-names>KT</given-names></name><name><surname>Borg</surname><given-names>PT</given-names></name><name><surname>Nenonen</surname><given-names>AM</given-names></name><name><surname>Fogelholm</surname><given-names>MG</given-names></name></person-group><article-title>Effects of a weight maintenance program with or without exercise
on the metabolic syndrome: a randomized trial in obese men</article-title><source>Prev Med</source><year>2005</year><volume>41</volume><issue>3-4</issue><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">16125218</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Marfella</surname><given-names>R</given-names></name><name><surname>Ciotola</surname><given-names>M</given-names></name><name><surname>Di Palo</surname><given-names>C</given-names></name><name><surname>Giugliano</surname><given-names>F</given-names></name><name><surname>Giugliano</surname><given-names>G</given-names></name><etal/></person-group><article-title>Effect of a Mediterranean-style diet on endothelial dysfunction
and markers of vascular inflammation in the metabolic syndrome: a randomized
trial</article-title><source>JAMA</source><year>2004</year><volume>292</volume><issue>12</issue><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="pmid">15383514</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Sim</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name></person-group><article-title>Effects of weight reduction on metabolic syndrome in Korean obese
patients</article-title><source>J Korean Med Sci</source><year>2004</year><volume>19</volume><issue>2</issue><fpage>202</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">15082891</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname><given-names>SC</given-names></name><name><surname>Damms-Machado</surname><given-names>A</given-names></name><name><surname>Betz</surname><given-names>C</given-names></name><name><surname>Herpertz</surname><given-names>S</given-names></name><name><surname>Legenbauer</surname><given-names>T</given-names></name><name><surname>Low</surname><given-names>T</given-names></name><etal/></person-group><article-title>Multicenter evaluation of an interdisciplinary 52-week weight
loss program for obesity with regard to body weight, comorbidities and
quality of life - a prospective study</article-title><source>Int J Obes (Lond)</source><year>2012</year><volume>36</volume><issue>4</issue><fpage>614</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">21673653</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalter-Lebovici</surname><given-names>O</given-names></name><name><surname>Younis-Zeidan</surname><given-names>N</given-names></name><name><surname>Atamna</surname><given-names>A</given-names></name><name><surname>Lubin</surname><given-names>F</given-names></name><name><surname>Alpert</surname><given-names>G</given-names></name><name><surname>Chetrit</surname><given-names>A</given-names></name><etal/></person-group><article-title>Lifestyle intervention in obese Arab women: a randomized
controlled Trial</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><issue>11</issue><fpage>970</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">20548010</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>KM</given-names></name><name><surname>Westborg</surname><given-names>CJ</given-names></name><name><surname>Eliasson</surname><given-names>MC</given-names></name></person-group><article-title>A randomized trial of lifestyle intervention in primary
healthcare for the modification of cardiovascular risk
factors</article-title><source>Scand J Public Health</source><year>2006</year><volume>34</volume><issue>5</issue><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">16990155</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landaeta-D&#x000ed;az</surname><given-names>L</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>JM</given-names></name><name><surname>Da Silva-Grigoletto</surname><given-names>M</given-names></name><name><surname>Rosado-Alvarez</surname><given-names>D</given-names></name><name><surname>G&#x000f3;mez-Gardu&#x000f1;o</surname><given-names>A</given-names></name><name><surname>G&#x000f3;mez-Delgado</surname><given-names>F</given-names></name><etal/></person-group><article-title>Mediterranean diet, moderate-to-high intensity training, and
health-related quality of life in adults with metabolic
syndrome</article-title><source>Eur J Prev Cardiol</source><year>2013</year><volume>20</volume><issue>4</issue><fpage>555</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">22496276</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katano</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>A</given-names></name><name><surname>Suzukamo</surname><given-names>Y</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><etal/></person-group><article-title>Relationship between health-related quality of life and
clustering of metabolic syndrome diagnostic components</article-title><source>Qual Life Res</source><year>2012</year><volume>21</volume><issue>7</issue><fpage>1165</fpage><lpage>1170</lpage><pub-id pub-id-type="pmid">21984466</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>ES</given-names></name><name><surname>Li</surname><given-names>C</given-names></name></person-group><article-title>Metabolic syndrome and health-related quality of life among U. S.
adults</article-title><source>Ann Epidemiol</source><year>2008</year><volume>18</volume><issue>3</issue><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">18280918</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corica</surname><given-names>F</given-names></name><name><surname>Corsonello</surname><given-names>A</given-names></name><name><surname>Apolone</surname><given-names>G</given-names></name><name><surname>Mannucci</surname><given-names>E</given-names></name><name><surname>Lucchetti</surname><given-names>M</given-names></name><name><surname>Bonfiglio</surname><given-names>C</given-names></name><etal/></person-group><article-title>Metabolic syndrome, psychological status and quality of life in
obesity: the QUOVADIS Study</article-title><source>Int J Obes (Lond)</source><year>2008</year><volume>32</volume><issue>1</issue><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">17653068</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JP</given-names></name><name><surname>Pozuelo</surname><given-names>L</given-names></name><name><surname>Brennan</surname><given-names>DM</given-names></name><name><surname>Hoar</surname><given-names>B</given-names></name><name><surname>Hoogwerf</surname><given-names>BJ</given-names></name></person-group><article-title>Association of SF-36 with coronary artery disease risk factors
and mortality: a PreCIS study</article-title><source>Prev Cardiol</source><year>2010</year><volume>13</volume><issue>3</issue><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">20626667</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madero</surname><given-names>M</given-names></name><name><surname>Arriaga</surname><given-names>JC</given-names></name><name><surname>Jalal</surname><given-names>D</given-names></name><name><surname>Rivard</surname><given-names>C</given-names></name><name><surname>McFann</surname><given-names>K</given-names></name><name><surname>P&#x000e9;rez-M&#x000e9;ndez</surname><given-names>O</given-names></name><etal/></person-group><article-title>The effect of two energy-restricted diets, a low-fructose diet
versus a moderate natural fructose diet, on weight loss and metabolic
syndrome parameters: a randomized controlled trial</article-title><source>Metabolism</source><year>2011</year><volume>60</volume><issue>11</issue><fpage>1551</fpage><lpage>1559</lpage><pub-id pub-id-type="pmid">21621801</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinger</surname><given-names>I</given-names></name><name><surname>Goodman</surname><given-names>C</given-names></name><name><surname>Hare</surname><given-names>DL</given-names></name><name><surname>Jerums</surname><given-names>G</given-names></name><name><surname>Selig</surname><given-names>S</given-names></name></person-group><article-title>The effect of resistance training on functional capacity and
quality of life in individuals with high and low numbers of metabolic risk
factors</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><issue>9</issue><fpage>2205</fpage><lpage>2210</lpage><pub-id pub-id-type="pmid">17563342</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarwer</surname><given-names>DB</given-names></name><name><surname>Moore</surname><given-names>RH</given-names></name><name><surname>Diewald</surname><given-names>LK</given-names></name><name><surname>Chittams</surname><given-names>J</given-names></name><name><surname>Berkowitz</surname><given-names>RI</given-names></name><name><surname>Vetter</surname><given-names>M</given-names></name><etal/><collab>POWER-UP Research Group</collab></person-group><article-title>The impact of a primary care-based weight loss intervention on
quality of life</article-title><source>Int J Obes (Lond)</source><year>2013</year><volume>37</volume><issue>Suppl 1</issue><fpage>S25</fpage><lpage>S30</lpage><pub-id pub-id-type="pmid">23921778</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishina</surname><given-names>M</given-names></name><name><surname>Nishina</surname><given-names>K</given-names></name><name><surname>Ohira</surname><given-names>T</given-names></name><name><surname>Makino</surname><given-names>K</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name></person-group><article-title>Associations of psychological distress with metabolic syndrome
among Japanese urban residents</article-title><source>J Atheroscler Thromb</source><year>2011</year><volume>18</volume><issue>5</issue><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">21325777</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>JA</given-names></name><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Davis-Lameloise</surname><given-names>N</given-names></name><name><surname>Philpot</surname><given-names>B</given-names></name><name><surname>Laatikainen</surname><given-names>T</given-names></name><name><surname>Kilkkinen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Depression: an important comorbidity with metabolic syndrome in a
general population</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><issue>12</issue><fpage>2368</fpage><lpage>2373</lpage><pub-id pub-id-type="pmid">18835951</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skilton</surname><given-names>MR</given-names></name><name><surname>Moulin</surname><given-names>P</given-names></name><name><surname>Terra</surname><given-names>JL</given-names></name><name><surname>Bonnet</surname><given-names>F</given-names></name></person-group><article-title>Associations between anxiety, depression, and the metabolic
syndrome</article-title><source>Biol Psychiatry</source><year>2007</year><volume>62</volume><issue>11</issue><fpage>1251</fpage><lpage>1257</lpage><pub-id pub-id-type="pmid">17553465</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Reedt Dortland</surname><given-names>AK</given-names></name><name><surname>Giltay</surname><given-names>EJ</given-names></name><name><surname>Van Veen</surname><given-names>T</given-names></name><name><surname>Zitman</surname><given-names>FG</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name></person-group><article-title>Metabolic syndrome abnormalities are associated with severity of
anxiety and depression and with tricyclic antidepressant use</article-title><source>Acta Psychiatr Scand</source><year>2010</year><volume>122</volume><issue>1</issue><fpage>30</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">20456284</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luppino</surname><given-names>FS</given-names></name><name><surname>Van Reedt Dortland</surname><given-names>AK</given-names></name><name><surname>Wardenaar</surname><given-names>KJ</given-names></name><name><surname>Bouvy</surname><given-names>PF</given-names></name><name><surname>Giltay</surname><given-names>EJ</given-names></name><name><surname>Zitman</surname><given-names>FG</given-names></name><etal/></person-group><article-title>Symptom dimensions of depression and anxiety and the metabolic
syndrome</article-title><source>Psychosom Med</source><year>2011</year><volume>73</volume><issue>3</issue><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">21257975</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>D</given-names></name><name><surname>Phillips</surname><given-names>AC</given-names></name><name><surname>Thomas</surname><given-names>GN</given-names></name><name><surname>Gale</surname><given-names>CR</given-names></name><name><surname>Deary</surname><given-names>I</given-names></name><name><surname>Batty</surname><given-names>GD</given-names></name></person-group><article-title>Generalized anxiety disorder is associated with metabolic
syndrome in the Vietnam experience study</article-title><source>Biol Psychiatry</source><year>2009</year><volume>66</volume><issue>1</issue><fpage>91</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">19344891</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab><collab>Secretaria de Aten&#x000e7;&#x000e3;o &#x000e0; Sa&#x000fa;de</collab><collab>Coordena&#x000e7;&#x000e3;o-Geral da Pol&#x000ed;tica de
Alimenta&#x000e7;&#x000e3;o e Nutri&#x000e7;&#x000e3;o</collab></person-group><source>Guia alimentar para a popula&#x000e7;&#x000e3;o brasileira: promovendo a
alimenta&#x000e7;&#x000e3;o saud&#x000e1;vel</source><publisher-loc>Bras&#x000ed;lia</publisher-loc><year>2005</year></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Velasquez</surname><given-names>M</given-names></name><name><surname>Maurer</surname><given-names>G</given-names></name><name><surname>Crouch</surname><given-names>C</given-names></name><name><surname>DiClemente</surname><given-names>C</given-names></name></person-group><source>Group treatment for substance abuse:a stages-of- change therapy
manual</source><publisher-loc>New York</publisher-loc><publisher-name>The Guilford Press</publisher-name><year>2001</year></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chobanian</surname><given-names>AV</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Green</surname><given-names>LA</given-names></name><name><surname>Izzo</surname><given-names>JL</given-names></name><etal/><collab>National Heart, Lung, and Blood Institute Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood
Pressure</collab><collab>National High Blood Pressure Education Program Coordinating
Committee</collab></person-group><article-title>The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7
report</article-title><comment>Erratum in JAMA. 2003;290(2):197</comment><source>JAMA</source><year>2003</year><volume>289</volume><issue>19</issue><fpage>2560</fpage><lpage>2572</lpage><pub-id pub-id-type="pmid">12748199</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lohman</surname><given-names>TG</given-names></name><name><surname>Roche</surname><given-names>AF</given-names></name><name><surname>Martorell</surname><given-names>R</given-names></name></person-group><source>Anthropometric Standardization Reference Manual</source><publisher-loc>Champaign</publisher-loc><publisher-name>Human Kinetics Books</publisher-name><year>1988</year></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Achenbach</surname><given-names>TM</given-names></name><name><surname>Rescorla</surname><given-names>LA</given-names></name></person-group><source>Manual for the ASEBA adult forms &#x00026; profiles</source><publisher-loc>Burlington, VT</publisher-loc><publisher-name>University of Vermont, Research Center for Children, Youth,
&#x00026; Families</publisher-name><year>2003</year></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciconelli</surname><given-names>RM</given-names></name><name><surname>Ferraz</surname><given-names>MB</given-names></name><name><surname>Santos</surname><given-names>W</given-names></name><name><surname>Mein&#x000e3;o</surname><given-names>I</given-names></name><name><surname>Quaresma</surname><given-names>MR</given-names></name></person-group><article-title>Brazilian-Portuguese version of the SF-36. A reliable and valid
quality of life outcome measure</article-title><source>Rev Bras Reumatol</source><year>1999</year><volume>39</volume><issue>3</issue><fpage>143</fpage><lpage>150</lpage></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindholm</surname><given-names>LH</given-names></name><name><surname>Ekbom</surname><given-names>T</given-names></name><name><surname>Dash</surname><given-names>C</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Tibblin</surname><given-names>G</given-names></name><name><surname>Schersten</surname><given-names>B</given-names></name></person-group><article-title>The impact of health care advice given in primary care on
cardiovascular risk. CELL Study Group</article-title><source>BMJ</source><year>1995</year><volume>310</volume><issue>6987</issue><fpage>1105</fpage><lpage>1109</lpage><pub-id pub-id-type="pmid">7742677</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Picard</surname><given-names>P</given-names></name><name><surname>Vol</surname><given-names>S</given-names></name><name><surname>Fezeu</surname><given-names>L</given-names></name><name><surname>Eschwege</surname><given-names>E</given-names></name><collab>DESIR Study Group</collab></person-group><article-title>Consequences of change in waist circumference on cardiometabolic
risk factors over 9 years: data from an Epidemiological Study on the Insulin
Resistance Syndrome (DESIR)</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><issue>7</issue><fpage>1901</fpage><lpage>1903</lpage><pub-id pub-id-type="pmid">17468349</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>EG</given-names></name><name><surname>Bang</surname><given-names>SY</given-names></name><name><surname>Hyun</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chu</surname><given-names>SH</given-names></name><name><surname>Jeon</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Effects of a 6-month lifestyle modification intervention on the
cardiometabolic risk factors and health-related qualities of life in women
with metabolic syndrome</article-title><source>Metabolism</source><year>2010</year><volume>59</volume><issue>7</issue><fpage>1035</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">20045151</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Neiberg</surname><given-names>RH</given-names></name><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Clark</surname><given-names>JM</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>Hill</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Four-year weight losses in the look AHEAD study: factors
associated with long-term success</article-title><source>Obesity (Silver Spring)</source><year>2011</year><volume>19</volume><issue>10</issue><fpage>1987</fpage><lpage>1998</lpage><pub-id pub-id-type="pmid">21779086</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f8;ltoft</surname><given-names>F</given-names></name><name><surname>Hammer</surname><given-names>M</given-names></name><name><surname>Kragh</surname><given-names>N</given-names></name></person-group><article-title>The association of body mass index and health-related quality of
life in the general population: data from the 2003 Health Survey of
England</article-title><source>Qual Life Res</source><year>2009</year><volume>18</volume><issue>10</issue><fpage>1293</fpage><lpage>1299</lpage><pub-id pub-id-type="pmid">19813103</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetter</surname><given-names>ML</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Lavenberg</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>RH</given-names></name><name><surname>Volger</surname><given-names>S</given-names></name><name><surname>Perez</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Relation of health-related quality of life to metabolic syndrome,
obesity, depression and comorbid illnesses</article-title><comment>Erratum in Int J Obes (Lond). 2012;36(2):325-6</comment><source>Int J Obes (Lond)</source><year>2011</year><volume>35</volume><issue>8</issue><fpage>1087</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">21042326</pub-id></element-citation></ref></ref-list></back></article>